Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells

Biochem Biophys Res Commun. 2003 Jun 13;305(4):797-805. doi: 10.1016/s0006-291x(03)00853-2.

Abstract

We previously reported synergistic induction of apoptosis by IFN-gamma plus either cyclosporin A (CsA) or tacrolimus (FK506) in gastric carcinoma cells. In this study, we aimed to elucidate the mechanism for this synergistic induction of apoptosis. IFN-gamma plus CsA synergistically induced caspase-3 mediated apoptosis in gastric carcinoma cells. Although IFN-gamma induced activation of signal transducer and activator of transcription1 (STAT1) and expression of interferon regulatory factor-1 (IRF-1) mRNA, IFN-gamma alone was not able to induce caspase-3 activation and apoptosis. When gastric carcinoma cells were treated with cyclohexamide, a protein synthesis inhibitor, following IFN-gamma pretreatment, caspase-3 was activated, and apoptosis was markedly induced. These findings suggest the existence of IFN-gamma-induced anti-apoptotic pathway and we evaluated the effect of IFN-gamma and CsA on calcium-sensitive nuclear factor-kappa B (NF-kappa B) activation. IFN-gamma increased intracellular calcium ion concentration ([Ca(2+)](i)) consisting of a spike and a sustained phase, and the latter was completely abrogated by CsA. Activation of NF-kappa B occurred in response to IFN-gamma, and which was markedly inhibited by either CsA or FK506. NF-kappa B decoy also enhanced the cytotoxic effect of IFN-gamma. These results suggest that IFN-gamma may simultaneously induce the STAT1-mediated apoptotic pathway and the anti-apoptotic pathway through calcium-activated NF-kappa B and that inhibition of the latter by CsA may result in dominance of the apoptosis-inducing pathway.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis*
  • Calcium / metabolism
  • Carcinoma / genetics
  • Carcinoma / metabolism*
  • Carcinoma / pathology
  • Caspase 3
  • Caspases / metabolism
  • Cycloheximide / pharmacology
  • Cyclosporine / pharmacology*
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Drug Synergism
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon-gamma / pharmacology*
  • Models, Biological
  • NF-kappa B / antagonists & inhibitors*
  • Phosphoproteins / biosynthesis
  • Phosphoproteins / genetics
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Messenger / biosynthesis
  • STAT1 Transcription Factor
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology
  • Tacrolimus / pharmacology
  • Trans-Activators / metabolism
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • NF-kappa B
  • Phosphoproteins
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Trans-Activators
  • Interferon-gamma
  • Cyclosporine
  • Cycloheximide
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Calcium
  • Tacrolimus